CATALYST PHARMACEUTICALS, INC. (CPRX)

SEC filing

CATALYST PHARMACEUTICALS, INC.

CPRX · CIK 1369568

4 · Dec 16, 2025 · Harper Molly sold 26.75K shares at $23.25/share ($621.9K); exercised options for 20K shares

Harper Molly sold 26.75K shares at $23.25/share ($621.9K); exercised options for 20K shares

FORM 4 FOR 12-12-2025

xslF345X05/form_4.xmlSEC.gov

Graphics and non-inline formats (not embedded below).